Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5067240019 | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
5067241015 | Product containing bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Bacitracin- and neomycin- and sulfacetamide-containing product | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Sulfacetamide-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Bacitracin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Is a | Neomycin-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Sulfacetamide | true | Inferred relationship | Some | 1 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Neomycin | true | Inferred relationship | Some | 2 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has active ingredient | Bacitracin | true | Inferred relationship | Some | 3 | |
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form | Is a | True | Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets